Insulin Requirement Profiles of Short-Term Continuous Subcutaneous Insulin Infusion Therapy in Chinese Patients with Type 2 Diabetic Nephropathy

被引：0
|
作者：
Lin, Shuo
Zhang, Kuixing
Li, Ping
Fang, Ke
Zeng, Longyi
机构：
来源：
DIABETES | 2019年 / 68卷
关键词：
D O I：
10.2337/db19-1062-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1062-P
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Good metabolic control with a continuous subcutaneous insulin infusion (CSII) in type 2 diabetic patients uncontrolled by insulin optimisation
    Donnet, J. -P.
    Courreges, J-P.
    Clavel, S.
    Gabreau, T.
    Gouet, D.
    Verlet, E.
    Cosson, E.
    Jan, P.
    Cirette, B.
    Leutenegger, E.
    DIABETOLOGIA, 2010, 53
  • [42] The comparison of insulin aspart and human soluble insulin used in continuous subcutaneous insulin infusion in newly diagnosed type 2 diabetic patients
    Li, Y
    Liu, J
    Liao, Z
    Huang, ZM
    Weng, HP
    DIABETES, 2005, 54 : A106 - A107
  • [43] Hyperinsulinemia and hypofibrinolysis: Effects of short-term optimized glycemic control with continuous insulin infusion in type II diabetic patients
    Lormeau, B
    Aurousseau, MH
    Valensi, P
    Paries, J
    Attali, JR
    METABOLISM-CLINICAL AND EXPERIMENTAL, 1997, 46 (09): : 1074 - 1079
  • [44] Efficacy of short term continuous subcutaneous insulin lispro versus continuous intravenous regular insulin in poorly controlled, hospitalized, type 2 diabetic patients
    Boullu-Sanchis, S.
    Ortega, F.
    Chabrier, G.
    Busch, M. S.
    Uhl, C.
    Pinget, M.
    Jeandidier, N.
    DIABETES & METABOLISM, 2006, 32 (04) : 350 - 357
  • [45] Short-Term Continuous Subcutaneous Insulin Infusion Combined with Insulin Sensitizers Rosiglitazone, Metformin, or Antioxidant α-Lipoic Acid in Patients with Newly Diagnosed Type 2 Diabetes Mellitus
    Huang, Zhimin
    Wan, Xuesi
    Liu, Juan
    Deng, Wanping
    Chen, Ailing
    Liu, Liehua
    Liu, Jianbin
    Wei, Guohong
    Li, Hai
    Fang, Donghong
    Li, Yanbing
    DIABETES TECHNOLOGY & THERAPEUTICS, 2013, 15 (10) : 859 - 869
  • [46] SHORT AND LONG-TERM CONTINUOUS SUBCUTANEOUS INSULIN INFUSION (CSII) IN PATIENTS WITH DIABETIC AUTONOMIC NEUROPATHY (DAN)
    BELLAVERE, F
    FEDELE, FD
    CARDONE, C
    FERRI, M
    TIENGO, A
    CREPALDI, G
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 1983, 6 (03): : 160 - 160
  • [47] Comparison of continuous subcutaneous insulin infusion and multiple daily insulin injections in Chinese patients with type 2 diabetes mellitus
    Yang, Honghong
    Heng, Xueyuan
    Liang, Cuige
    Liu, Xiaomeng
    Du, Wenhua
    Li, Shoujie
    Wang, Yueli
    Dong, Qingyu
    Li, Wenxia
    Pan, Zhenyu
    Gong, Qian
    Gao, Guanqi
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2014, 42 (04) : 1002 - 1010
  • [48] SHORT AND LONG-TERM CONTINUOUS SUBCUTANEOUS INSULIN INFUSION SYSTEM TREATMENT IN PATIENTS WITH DIABETIC AUTONOMIC NEUROPATHY
    CREPALDI, G
    BELLAVERE, F
    CARDONE, C
    BOSELLO, G
    FEDELE, D
    DIABETOLOGIA, 1982, 23 (02) : 162 - 162
  • [49] Treatment Efficacy of Subcutaneous Insulin Infusion Therapy In Type 1 Diabetic Patients
    Cander, Soner
    Kiyici, Sinem
    Deligonul, Adem
    Gul, Ozen Oz
    Uonal, Oguz Kaan
    Sakalli, Mustafa
    Tuncel, Ercan
    Imamoglu, Sazi
    TURKISH JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2010, 14 (04) : 80 - 84
  • [50] Effect of a short-term intravenous insulin-infusion on severe insulin-resistance in insulin-dependent type 2-diabetic patients
    Biesenbach, G
    Grafinger, P
    DIABETES, 2001, 50 : A430 - A431
12345